Acasti, seeking to expand use of old steroid, posts clinical data on oral spray in rare disease

Acasti Pharma has shared early clinical data on its betamethasone oral-mucosal metered spray, providing preliminary validation of its belief the delivery format can address an unmet need in a rare, childhood neurological disorder.